| Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ... New England Journal of Medicine 386 (16), 1532-1546, 2022 | 2485* | 2022 |
| Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The Lancet 399 (10332), 1303-1312, 2022 | 1272 | 2022 |
| Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA. 1 JLH Tsui, JT McCrone, B Lambert, S Bajaj, RPD Inward, P Bosetti, ... Science 381 (6655), 336-343, 2023 | 39 | 2023 |
| Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October … G Dabrera, H Allen, A Zaidi, J Flannagan, K Twohig, S Thelwall, ... Eurosurveillance 27 (20), 2100377, 2022 | 34* | 2022 |
| Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA. 2 compared to BA. 1 in England HH Webster, T Nyberg, MA Sinnathamby, NA Aziz, N Ferguson, ... Nature Communications 13 (1), 6053, 2022 | 29 | 2022 |
| Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with … FCM Kirsebom, K Harman, RJ Lunt, N Andrews, N Groves, NA Aziz, ... The Lancet Regional Health–Europe 35, 2023 | 21 | 2023 |
| High attack rate in a large care home outbreak of SARS-CoV-2 BA. 2.86, East of England, August 2023 L Reeve, E Tessier, A Trindall, NIBA Aziz, N Andrews, M Futschik, ... Eurosurveillance 28 (39), 2300489, 2023 | 15 | 2023 |
| Risk of severe outcomes among SARS-CoV-2 Omicron BA. 4 and BA. 5 cases compared to BA. 2 cases in England NA Aziz, SG Nash, A Zaidi, T Nyberg, N Groves, R Hope, JL Bernal, ... The Journal of infection 87 (1), e8, 2023 | 9 | 2023 |
| Risk of severe outcomes among Omicron sub-lineages BA. 4.6, BA. 2.75, and BQ. 1 compared to BA. 5 in England G Seghezzo, SG Nash, NA Aziz, R Hope, JL Bernal, E Gallagher, ... Epidemiology & Infection 151, e189, 2023 | 2 | 2023 |
| Descriptive Epidemiology of Travel and Non‐Travel Related SARS‐CoV‐2 Gamma (P. 1/501Y. V3) Variant Cases in England, 2021 N Abdul Aziz, K Twohig, M Sinnathamby, A Zaidi, S Aliabadi, N Groves, ... Influenza and Other Respiratory Viruses 18 (5), e13308, 2024 | 1* | 2024 |
| Mixture modelling of Bordetella pertussis serology samples to evaluate anti-pertussis toxin immunoglobulin G titre thresholds for positivity: England 2008–2022 E Tessier, D Litt, S Ribeiro, N Abdul Aziz, H Campbell, G Amirthalingam, ... Journal of Medical Microbiology 72 (12), 001774, 2023 | 1 | 2023 |
| The impact of COVID‐19 on residents of long‐term care facilities with learning disabilities and/or autism E Tessier, H Webster, NA Aziz, J Flannagan, A Zaidi, A Charlett, ... Influenza and Other Respiratory Viruses 17 (4), e13139, 2023 | 1 | 2023 |
| Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks J Flannagan, DY Chudasama, R Hope, SM Collin, A Bhattacharya, ... Epidemiology & Infection 151, e191, 2023 | 1 | 2023 |
| Setting thresholds to determine COVID-19 activity levels using the mean standard deviation (MSD) method, England, 2022–2024 MA Sinnathamby, T Bourouphael, J Boateng, M Collonnaz, C Quinot, ... Eurosurveillance 29 (45), 2400696, 2024 | | 2024 |
| Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and symptomatic infection in the England Winter Coronavirus (COVID-19) Infection Study cohort N Abdul Aziz, N Andrews, C Rawlinson, A Buckley, A Allen medRxiv, 2024.12. 30.24319550, 2024 | | 2024 |
| Descriptive epidemiology of COVID-19 outcomes in England, from September 2023 to April 2024 N Abdul Aziz, H Allen, K Assaraf, G Dabrera, M Ramsay, A Allen medRxiv, 2024.11. 12.24317146, 2024 | | 2024 |
| Time-varying reproduction number estimation: Fusing compartmental models with generalised additive models I Hall, X Pang, L Pellis, T House, Y Han, N Abdul Aziz, E Tessier medRxiv, 2024.03. 26.24304928, 2024 | | 2024 |
| Descriptive epidemiology of SARS‐CoV‐2 Beta (B. 1.351) variant cases in England, December 2020 to June 2022 MA Sinnathamby, A Zaidi, KA Twohig, S Aliabadi, NA Aziz, N Groves, ... Influenza and Other Respiratory Viruses 17 (11), e13204, 2023 | | 2023 |
| Building a novel address enrichment approach to monitor COVID-19 cases in prisons in England throughout the pandemic, evaluated against published data E Tessier, NA Aziz, S Willner, J Boateng, J Lewis, B Cook, A Woods, ... | | |
| Detecting and evaluating COVID-19 outbreaks and positivity rates in prisons across England NA Aziz, E Tessier, C Rawlinson, K Harman, S Nash, S Willner, ... | | |
